YX9-16536-69043
3 vaccinations
5 coded responses
35 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 921 / CA
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Survey response — day 0, dose 1MedDRA: Headache — Feeling: Good · HeadacheFree text: Headache may not be vaccine related.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-22
- 2021-01-27
-
2021-02-03
Dose 2 — Pfizer-BioNTech
- 2021-02-03
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-02-06
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-10
- 2021-02-17
-
2021-02-24
Survey response — day 21, dose 2MedDRA: Headache, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: 100.9° fever and headache yesterday, no other symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-05-05
-
2021-08-04
Survey response — 6 months, dose 2MedDRA: Fatigue, Night sweats, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: low grade recurring fever, severe fatigue, night sweatsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-04
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-10
-
2021-12-15
Dose 3 — Pfizer-BioNTech
-
2021-12-16
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Abdominal painAdult check-in
-
2021-12-18
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-12-19
- 2021-12-20
- 2021-12-21
- 2021-12-22
- 2021-12-29
- 2022-01-05
- 2022-01-12
- 2022-01-19
- 2022-01-26
-
2022-03-17
Survey response — 3 months, dose 3MedDRA: Influenza — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Flu symptoms since 3/14, slowly improvingMedDRA releases: 2024-11 · check-in free text available
-
2022-06-15
Survey response — 6 months, dose 3MedDRA: Pregnancy, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Pregnancy, positive COVID-19 testMedDRA releases: 2024-11 · check-in free text available
-
2022-06-15
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-06-17
- 2022-06-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech | |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-15 | priority 2/3 | |
| 2021-08-04 | Unsuccessful | |
| 2022-06-15 | Unsuccessful |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Headache may not be vaccine related.
Release 4 — day 21, dose 2
Symptoms: 100.9° fever and headache yesterday, no other symptoms
Release 9 — 6 months, dose 2
Symptoms: low grade recurring fever, severe fatigue, night sweats
Release 11 — 3 months, dose 3
Symptoms: Flu symptoms since 3/14, slowly improving
Release 12 — 6 months, dose 3
Symptoms: Pregnancy, positive COVID-19 test
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Night sweats | ✓ | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release